10.1016/j.febslet.2007.05.023
Consider that immediate can range from a few hours to a day post-injection, depending on the individuals metabolism and overall health
Rare Concerns Allergic reactions to GHK-Cu remain rare but possible, particularly in individuals with copper sensitivity
April 15, 2026: In the updated 503A document, the FDA announced it is removing BPC-157 (both BPC-157 acetate and BPC-157 free base) from Category 2 and scheduling a PCAC meeting for July 23, 2026
However, those with specific autoimmune conditions (particularly psoriasis or rosacea, where LL-37 is naturally overexpressed locally) should consult with their healthcare provider, as adding exogenous LL-37 could potentially exacerbate hyper-immune responses in those highly specific contexts
Last reviewed: June 7, 2026 Read article Product resources What vial size is listed for BPC-157